课题基金 / 基金详情

Developing and evaluating a framework for the rational design of antibiotic prescribing policies in resource-constrained hospital settings

Developing and evaluating a framework for the rational design of antibiotic prescribing policies in resource-constrained hospital settings
开发和评估资源有限的医院环境中合理设计抗生素处方政策的框架
批准号:
MR/K006924/1
负责人:
Ben Cooper
金额:
$260.47万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --

项目摘要

项目成果

Ben Cooper的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
When hospitalised patients have a serious bacterial infection, they are usually given antibiotics. In rich countries, one third of the time the antibiotics are ineffective. This is often because the bacteria have acquired a gene that makes them resistant to that antibiotic. While it is possible to test for such resistance, it takes three or four days to get a result. For patients with serious infections this delay can be the difference between life and death.In lower income countries the same is likely to be true, but little data are available. We do, however, know that patients in hospitals in poorer countries get infections more often and when they do they are more likely to die. Infections caused by antibiotic-resistant bacteria are also a major problem. As well as delaying effective treatment, such resistance can claim lives in low-income settings because remaining effective antibiotics are not available. Even if they are, they may be too expensive for many patients. The research aims to address the question of how we can more often give patients effective antibiotics when they need them and less often when they don't in hospitals with limited resources. We also want to find out how different antibiotics affect the spread of the most dangerous antibiotic-resistant bacteria, and we want to see if by changing patterns of antibiotic prescribing we can reduce the number of infections with resistant bacteria.One part of the proposed work will use patient data (age, time in hospital, date last hospitalised, etc) and look for patterns that help to predict how likely infections with different types of bacteria are. For example, we know that patients who have been in hospital a long time are more likely to have infections with resistant bacteria. We can use this information to help choose which antibiotic is most likely to be effective. Our hunch is that by using computer models we can make optimal use of the information and choose an effective antibiotic more often than currently happens.The second consideration doctors have to take into account when prescribing antibiotics is how this will affect other patients. The reason is that the more an antibiotic is used the more it creates an environment favourable to antibiotic-resistant bacteria. In general, increasing antibiotic use is associated with increased resistance to that antibiotic. The specifics, however, are complicated: some antibiotics promote resistance much more than others, and sometimes use of one antibiotic can cause an increase in resistance against a completely different antibiotic. To help design good antibiotic policies we need to understand these complex mechanisms better. Another part of the work will therefore use a computer modelling approach and new statistical techniques to develop and apply better methods to understand how levels of resistance change in response to changing antibiotic use. The next stage of the research will combine these computer models and make extensive use of expertise from infectious disease doctors to design the best antibiotic policy we can for two hospitals. We will evaluate new policies in two ways: first we will run computer simulations, using real data from the hospitals to predict how well the new policy performs. If it performs worse than current practice we will redesign the policy until it performs better. Then, in one of the hospitals, we will perform an intervention study where we introduce the new policy and evaluate whether it really does improve antibiotic prescribing and reduce resistance as predicted.Finally, use of new rapid tests that help determine what type of bugs are causing an infection can mean a patient has more chance of getting effective antibiotic treatment when it is needed and less chance of unnecessary treatment. We will use the previously-developed computer models to estimate how much patients would benefit from such tests, and evaluate which would represent good value for money.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1101/436006
发表时间: 2018-10
期刊: bioRxiv
影响因子: --
作者: [Thomas Crellen;P. Turner;Sreymom Pol;S. Baker;T. Nguyen;N. Stoesser;N. Day;B. Cooper]
通讯作者: Thomas Crellen;P. Turner;Sreymom Pol;S. Baker;T. Nguyen;N. Stoesser;N. Day;B. Cooper
DOI: 10.1093/aje/kwu360
发表时间: 2015-06-01
期刊: American journal of epidemiology
影响因子: 5
作者: [Cooper BS, Kotirum S, Kulpeng W, Praditsitthikorn N, Chittaganpitch M, Limmathurotsakul D, Day NP, Coker R, Teerawattananon Y, Meeyai A]
通讯作者: Meeyai A
More Research Is Needed to Quantify Risks, Benefits, and Cost-Effectiveness of Universal Mupirocin Usage.
需要更多的研究来量化普遍使用莫匹罗星的风险、益处和成本效益。
DOI: 10.1093/cid/ciw077
发表时间: 2016
期刊: an official publication of the Infectious Diseases Society of America
影响因子: --
作者: [Deeny SR]
通讯作者: Deeny SR
Metrics for Public Health Perspective Surveillance of Bacterial Antibiotic Resistance in Low- and Middle-Income Countries
低收入和中等收入国家细菌抗生素耐药性的公共卫生视角监测指标
DOI: 10.1101/2020.02.10.941930
发表时间: 2020
期刊:
影响因子: --
作者: [Auguet O]
通讯作者: Auguet O
7
    Optimising community antibiotic use and infection control with behavioural interventions in rural Burkina Faso and DR Congo
    • 批准号:
      MR/W031272/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $63.25万
    • 财政年份:
      2022
    • 负责人:
      Ben Cooper
    • 依托单位:
    Understanding and modelling reservoirs, vehicles and transmission of ESBL-producing Enterobacteriaceae in the community and long term care facilities
    • 批准号:
      MR/R004536/1
    • 项目类别:
      Research Grant
    • 资助金额:
      $38.73万
    • 财政年份:
      2017
    • 负责人:
      Ben Cooper
    • 依托单位:
    海外基金